Population Pharmacokinetics and Pharmacodynamics of Doxorubicin and Cyclophosphamide in Breast Cancer Patients: A Study by the EORTC-PAMM-NDDG

Author： Joerger Markus   Huitema Alwin D.R.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.46, Iss.12, 2007-01, pp. : 1051-1068

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese Patients

By >  

Clinical Pharmacokinetics, Vol. 50, Iss. 11, 2011-11 ,pp. : 739-750

Adis International

Access to resources Recommend Favorite

Doxorubicin plus Ifosfamide as Salvage Treatment for Patients with Advanced Breast Cancer Refractory to Epirubicin plus Cyclophosphamide

By Polyzos A.  

Clinical Drug Investigation, Vol. 19, Iss. 5, 2000-05 ,pp. : 349-355

Adis International

Access to resources Recommend Favorite

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients

By Lal Suman   Wong Zee Wan   Jada Srinivasa Rao   Xiang Xiaoqiang   Chen Shu Xiao   Ang Peter Cher Siang   Figg William D   Lee Edmund JD   Chowbay Balram  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 567-575

Future Medicine

Access to resources Recommend Favorite

Software for Population Pharmacokinetics and Pharmacodynamics

By Aarons L.  

Clinical Pharmacokinetics, Vol. 36, Iss. 4, 1999-04 ,pp. : 255-264

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacodynamics of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 10, 2015-10 ,pp. : 595-604

John Wiley & Sons Inc

Access to resources Recommend Favorite